NOAMI BLUMENBERG: Open Payments
NPI 1497343420 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 57 payments from 13 companies in 2025. Trend: 2023 $610 · 2024 $940 · 2025 $1,174
Food & beverage: $1,123Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $537 |
| Janssen Biotech, Inc. | 18 | $230 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Ardelyx, Inc. | 2 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $57 |
| GENZYME CORPORATION | 1 | $41 |
| PFIZER INC. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
Products named: RINVOQ, TREMFYA, SKYRIZI, CREON, XIFAXAN, DUPIXENT, IBSRELA, IQIRVO.
Industry payments across CO — which companies pay providers there.
